¥13.73
+
¥0.15 (1.09%)
End-of-day quote: 05/16/2024
SZSE:002019
Yifan Pharmaceutical Annual Report
| Year | Year | 2013 | 2012 | 2011 | 2010 | 2009 | 2006 | ||
|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
¥1.16B | ¥644.19M | ¥495.73M | ¥379.88M | ¥405.99M | ¥347.91M | |
| GM % | Gross Margin % |
|
31.23% | 22.79% | -10.97% | 26.14% | 33.40% | 35.29% | |
| OM | Operating Margin |
|
13.34% | 3.22% | -39.04% | -6.04% | 9.90% | 7.54% | |
| EPS | Earnings Per Share |
|
¥0.00 | ¥0.05 | ¥-0.09 | ¥-0.41 | ¥-0.34 | ¥0.05 | ¥0.00 |
| Div. | Dividends |
|
¥0.00 | ¥0.00 | ¥0.00 | ¥0.00 | ¥0.00 | ¥0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
551.05m | 551.05m | 551.05m | 551.05m | 551.05m | 477.75m | |
| OCF | Operating Cash Flow |
|
¥34.32M | ¥29.88M | ¥-52.82M | ¥-33.82M | ¥58.59M | ¥32.62M | |
| FCF | Free Cash Flow |
|
¥9.72M | ¥-37.76M | ¥-152.56M | ¥-233.14M | ¥-92.68M | ¥-25.00M | |
| FCFS | Free Cash Flow Per Share |
|
¥0.02 | ¥-0.07 | ¥-0.28 | ¥-0.42 | ¥-0.18 | ¥-0.06 |
